Koichi Mikami
Dados Biográficos
| ID | 6288377 |
|---|---|
| NOME | Koichi Mikami |
| PRENOMES | Koichi |
| SOBRENOME | Mikami |
| ASSINATURA | MIKAMI K |
| AFILIAÇÕES | Keio University |
| ORCID | 0000-0002-6274-4713 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 14 |
| TOTAL DE CITAÇÕES | 15 |
| TOTAL COMO AUTOR | 14 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2012 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2026 |
| ÍNDICE H | 2 |
Welcome toトピアTopia
We have written the introduction to this special issue on responsible research and innovation (RRI) in the UK and Japan as a visitor's guide to an imaginary island holiday park to emphasize how we have centered the situatedness of practices that contribute to responsibility in science and technology. Our overarching argument is that RRI cannot be discussed as a program without foregrounding its location, and that RRI therefore needs “alternative …
The Rise of Public Engagement in Japan and the UK
This paper juxtaposes major historical developments in public engagement in Japan and the UK to unsettle the idea that the UK experience of how “publics” have been accounted for in science policy might be taken as a common or representative story. In comparison to the UK and European moves “from deficit to dialogue,” recent events in Japan are much less well-known internationally, and do not follow the same pattern. Rather than being either “ahea…
A historical analysis of the policy on intractable diseases in Japan and its peculiarity
This article examines the history of the policy concerning a class of diseases called intractable diseases in Japan with a particular focus on the roles of patient support groups in firstly legitimizing the grouping of such diseases and then shaping the nature of the support that the Japanese Ministry of Health and Welfare provided to the patients and their families affected by them. The Ministry started its policy on intractable diseases in 1972…
The Value of the Map and the Place of STS
In the 2020 Prague Virtual Conference of the Society for Social Studies of Science (4S), Sharon Traweek was awarded the society’s John D. Bernal Prize jointly with Langdon Winner, for her distinguished contributions to the field of STS. In this essay responding to Traweek’s Bernal Lecture, I explore the continuing relevance of her work for Japan’s STS community. Even though this community has grown rapidly since the beginning of the 2000s, I argu…
Elsi is Our Next Battlefield
ELSI refers to “ethical, legal, and social issues/implications” of science and technology (S&T). The term has been gaining currency in Japan over the last 15 years in the context of its national S&T policy. In this essay, we argue that ELSI will become a pivotal concept characterizing the relationship between S&T and social sciences and humanities (SSH) in the country, due particularly to the first-ever amendment to the S&T Basic Law scheduled in…
Citizens under the umbrella
Social scientists have observed previously that patient support groups began to have significant influence over both research and clinical services of medical genetics in the early 2000s. This observation led to the idea of genetic citizenship, suggesting that the active participation and intervention of patient support groups in the rapidly growing field of medicine marked the emergence of a new form of citizenship. To understand how this citize…
STS as a Program of Ontological Disobedience
Is science and technology studies (STS) a luxury that our society cannot afford anymore? In this interview, Koichi Mikami tries to learn lessons from Steve Woolgar’s distinguished career on how the kind of sensibilities treasured within the field of STS and the type of critical engagement that its researchers aspire to might be best exercised in a changing landscape of higher education and academic research. Woolgar explains how he, at some key m…
The Case of Inferred Doability
On 28 January 2014, Haruko Obokata and her colleagues held a press conference regarding their new method of producing stem cells. The cells, named STAP (stimulus-triggered acquisition of pluripotency) cells, were of considerable interest not only for stem cell scientists but also for the wider society in Japan because both its government and citizens enjoyed the international reputation earned for the country by Shinya Yamanaka’s earlier success …
Tatsuya Mima, Risuku Ka Sareru Shintai—gendai Igaku to Touchi No Tekunorojī リスク化される身体 —現代医学と統治のテクノロジ [ Body as Risk—modern Medicine and the Technology of Governance ]
I sometimes wonder what the value(s) of critical sociological engagement with science for scientists themselves might be. As discussed in the critique of the so-called deficit model, no system of k
Orphans in the Market
This paper examines the history of orphan drug policy, from the emergence of 'orphans' in the American pharmaceutical market in the 1960s, through the debates and agitations that resulted in the passage of the US Orphan Drug Act of 1983, to attempts in the 1990s to prevent abuse of that Act and restore its original intentions. Although an increased number of drugs for rare diseases have since been developed and marketed, the extremely high price …
Local biologicals and the politics of standardization
In 2003, the United Kingdom and Japan had adopted relatively similar approaches to human embryonic stem cells science. The decade since has witnessed significant divergence in their national policies as differing responses to ethical questions about research use of human embryos emerged. The United Kingdom pursued a vision of ‘institutionally accredited stem cells’ by reconfiguring the role of the Human Fertilisation and Embryology Authority and …
Adoptable packages and the cost of their adoption
The goal of regenerative medicine is to utilize biological properties of cells for therapeutic purposes.Although substantial international investment has been made in this biomedical technology, the issue of which type of cells best serves for these purposes still remains unsettled.Adopting a conceptual framework from Clarke and Fujimura that the rightness of "tools" needs to be socially constructed, this paper examines the interactions of variou…
State-Supported Science and Imaginary Lock-in
Regenerative medicine (RM) in Japan lays strong emphasis on a specific trajectory of its development, which deploys human induced pluripotent stem (iPS) cells as the primary sources for the technology. The technique to create these stem cells was developed in 2006 by a Japanese stem cell scientist, Shinya Yamanaka, and since its applicability to human cells was established about a year later, this new type of cells has become to be considered as …
松本三和夫, Tekunosaiensu Risuku to Shakaigaku
State-Supported Science and Imaginary Lock-in
Regenerative medicine (RM) in Japan lays strong emphasis on a specific trajectory of its development, which deploys human induced pluripotent stem (iPS) cells as the primary sources for the technology. The technique to create these stem cells was developed in 2006 by a Japanese stem cell scientist, Shinya Yamanaka, and since its applicability to human cells was established about a year later, this new type of cells has become to be considered as …
Orphans in the Market
This paper examines the history of orphan drug policy, from the emergence of 'orphans' in the American pharmaceutical market in the 1960s, through the debates and agitations that resulted in the passage of the US Orphan Drug Act of 1983, to attempts in the 1990s to prevent abuse of that Act and restore its original intentions. Although an increased number of drugs for rare diseases have since been developed and marketed, the extremely high price …
松本三和夫, Tekunosaiensu Risuku to Shakaigaku
State-Supported Science and Imaginary Lock-in
Regenerative medicine (RM) in Japan lays strong emphasis on a specific trajectory of its development, which deploys human induced pluripotent stem (iPS) cells as the primary sources for the technology. The technique to create these stem cells was developed in 2006 by a Japanese stem cell scientist, Shinya Yamanaka, and since its applicability to human cells was established about a year later, this new type of cells has become to be considered as …
Adoptable packages and the cost of their adoption
The goal of regenerative medicine is to utilize biological properties of cells for therapeutic purposes.Although substantial international investment has been made in this biomedical technology, the issue of which type of cells best serves for these purposes still remains unsettled.Adopting a conceptual framework from Clarke and Fujimura that the rightness of "tools" needs to be socially constructed, this paper examines the interactions of variou…
Local biologicals and the politics of standardization
In 2003, the United Kingdom and Japan had adopted relatively similar approaches to human embryonic stem cells science. The decade since has witnessed significant divergence in their national policies as differing responses to ethical questions about research use of human embryos emerged. The United Kingdom pursued a vision of ‘institutionally accredited stem cells’ by reconfiguring the role of the Human Fertilisation and Embryology Authority and …
Tatsuya Mima, Risuku Ka Sareru Shintai—gendai Igaku to Touchi No Tekunorojī リスク化される身体 —現代医学と統治のテクノロジ [ Body as Risk—modern Medicine and the Technology of Governance ]
I sometimes wonder what the value(s) of critical sociological engagement with science for scientists themselves might be. As discussed in the critique of the so-called deficit model, no system of k
Orphans in the Market
This paper examines the history of orphan drug policy, from the emergence of 'orphans' in the American pharmaceutical market in the 1960s, through the debates and agitations that resulted in the passage of the US Orphan Drug Act of 1983, to attempts in the 1990s to prevent abuse of that Act and restore its original intentions. Although an increased number of drugs for rare diseases have since been developed and marketed, the extremely high price …
STS as a Program of Ontological Disobedience
Is science and technology studies (STS) a luxury that our society cannot afford anymore? In this interview, Koichi Mikami tries to learn lessons from Steve Woolgar’s distinguished career on how the kind of sensibilities treasured within the field of STS and the type of critical engagement that its researchers aspire to might be best exercised in a changing landscape of higher education and academic research. Woolgar explains how he, at some key m…
The Case of Inferred Doability
On 28 January 2014, Haruko Obokata and her colleagues held a press conference regarding their new method of producing stem cells. The cells, named STAP (stimulus-triggered acquisition of pluripotency) cells, were of considerable interest not only for stem cell scientists but also for the wider society in Japan because both its government and citizens enjoyed the international reputation earned for the country by Shinya Yamanaka’s earlier success …
Citizens under the umbrella
Social scientists have observed previously that patient support groups began to have significant influence over both research and clinical services of medical genetics in the early 2000s. This observation led to the idea of genetic citizenship, suggesting that the active participation and intervention of patient support groups in the rapidly growing field of medicine marked the emergence of a new form of citizenship. To understand how this citize…
The Value of the Map and the Place of STS
In the 2020 Prague Virtual Conference of the Society for Social Studies of Science (4S), Sharon Traweek was awarded the society’s John D. Bernal Prize jointly with Langdon Winner, for her distinguished contributions to the field of STS. In this essay responding to Traweek’s Bernal Lecture, I explore the continuing relevance of her work for Japan’s STS community. Even though this community has grown rapidly since the beginning of the 2000s, I argu…
Elsi is Our Next Battlefield
ELSI refers to “ethical, legal, and social issues/implications” of science and technology (S&T). The term has been gaining currency in Japan over the last 15 years in the context of its national S&T policy. In this essay, we argue that ELSI will become a pivotal concept characterizing the relationship between S&T and social sciences and humanities (SSH) in the country, due particularly to the first-ever amendment to the S&T Basic Law scheduled in…
A historical analysis of the policy on intractable diseases in Japan and its peculiarity
This article examines the history of the policy concerning a class of diseases called intractable diseases in Japan with a particular focus on the roles of patient support groups in firstly legitimizing the grouping of such diseases and then shaping the nature of the support that the Japanese Ministry of Health and Welfare provided to the patients and their families affected by them. The Ministry started its policy on intractable diseases in 1972…
Welcome toトピアTopia
We have written the introduction to this special issue on responsible research and innovation (RRI) in the UK and Japan as a visitor's guide to an imaginary island holiday park to emphasize how we have centered the situatedness of practices that contribute to responsibility in science and technology. Our overarching argument is that RRI cannot be discussed as a program without foregrounding its location, and that RRI therefore needs “alternative …
The Rise of Public Engagement in Japan and the UK
This paper juxtaposes major historical developments in public engagement in Japan and the UK to unsettle the idea that the UK experience of how “publics” have been accounted for in science policy might be taken as a common or representative story. In comparison to the UK and European moves “from deficit to dialogue,” recent events in Japan are much less well-known internationally, and do not follow the same pattern. Rather than being either “ahea…
Political science (10 obras) · Sociology (9 obras) · Law (8 obras) · Law (5 obras) · Politics (5 obras) · Biology (4 obras) · Biomedical Ethics and Regulation (4 obras) · Computer Science (4 obras) · Environmental ethics (4 obras) · Pluripotent Stem Cells Research (4 obras)